Aug 29 (Reuters) - Clinuvel Pharmaceuticals Ltd (CUV) :
- FY REVENUE FROM ORDINARY ACTIVITIES UP 19% TO A$78.3 MILLION
- FY NET PROFIT ATTRIBUTABLE UP 47% TO A$30.6 MILLION
- FULLY FRANKED FINAL DIVIDEND OF A$0.05 PER SHARE DECLARED
- EXPANSION TRAJECTORY WILL CONTINUE INTO FY24
News: CUV Clinuvel Pharmaceuticals Says FY Revenue From Ordinary Activities Up 19% To A$78.3 Mln
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$11.88 |
Change
0.360(3.13%) |
Mkt cap ! $600.9M | |||
| Open | High | Low | Value | Volume |
| $11.54 | $12.28 | $11.54 | $1.552M | 129.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 167 | $11.87 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.89 | 106 | 5 |
View Market Depth
| Last trade - 14.15pm 19/09/2025 (20 minute delay) ? |
| CUV (ASX) Chart |